Life Science Tools Market Size

  • Report ID: 6164
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Life Science Tools Market Size

Life Science Tools Market size was valued at USD 178.49 billion in 2024 and is set to exceed USD 726.31 billion by 2037, registering over 11.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of life science tools is evaluated at USD 194.77 billion.

The development of molecular diagnostics, rising R&D expenditures on drug discovery, the necessity for cost control in drug research, and technology improvements are all anticipated to bring up the price of tools used in life science. Increased emphasis on companion diagnostics and precision medicine is also anticipated to fuel market expansion.

Furthermore, factors including longer life expectancies and a rise in pharmaceutical outsourcing are expected to offer market participants significant development prospects in the upcoming years. For instance, the spending of major pharmaceutical companies on research and development increased by 6 percent a year (2001–20200). Big Pharma has launched 251 new medicines, accounting for 46 % of all approvals from the FDA (2001–20200). The efficiency of Big Pharma's 20 years of research and development investment is $6.16 billion for new drugs 2001 to 2020.


Life Science Tools Market Overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6164
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of life science tools is evaluated at USD 194.77 billion.

The life science tools market size was valued at USD 178.49 billion in 2024 and is set to exceed USD 726.31 billion by 2037, registering over 11.4% CAGR during the forecast period i.e., between 2025-2037. Increased emphasis on companion diagnostics and precision medicine will fuel the market growth.

North America industry is likely to hold largest revenue share of 38% by 2037, influenced by adoption of proteomics, oncology, and genomics, oncology, and diagnostic screening in the region.

The major players in the market are F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Merck KGaA, QIAGEN N.V., Oxford Instruments plc, GE HealthCare Technologies, Inc., Becton, Dickinson and Company, Shimadzu Corporation and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample